UK medical device market seen reaching $74.45 billion by 2035

The UK medical device market is projected to grow from $40.39 billion in 2025 to $74.45 billion by 2035, driven by an aging population, digital health adoption, and regulatory change. The outlook points to stronger demand for imaging, diagnostics, monitoring tools, and software-based devices across NHS and private care settings.

Why it matters: - The UK medical device market is on track for steady expansion over the next decade as healthcare demand shifts toward remote care, diagnostics, and connected devices. - Growth in this sector matters because it shapes what hospitals, clinics, and home care providers can buy for chronic disease management, early detection, and treatment planning. - The market outlook also points to investment opportunities in AI, telehealth, wearable devices, and sustainable products.

What happened: - Market Research Future projected the UK medical device market will rise to $74.45 billion by 2035 from $40.39 billion in 2025. - The forecast implies a 6.37% compound annual growth rate from 2025 through 2035. - The market was estimated at $37.74 billion in 2024. - The forecast was published Sept. 17, 2026. - The report highlighted a free sample and detailed insights.

The details: - The forecast was driven by rising demand for advanced diagnostic and treatment technologies. - The report said the UK population aged 65 and over is projected to reach 23 million by 2040. - The report linked market growth to increasing chronic disease burden and higher healthcare spending. - Software-based devices accounted for about 38% of market revenue in 2024. - Imaging devices held the largest device-type share in 2024 at 33%. - Diagnostic devices led application share in 2024 at 36%. - Hospitals accounted for 49% of end-user share in 2024. - Home care settings were the fastest-growing end-use segment. - Wearable devices were the fastest-growing technology segment. - Class II devices were the largest regulatory category. - The Medicines and Healthcare products Regulatory Agency framework and UKCA marking were cited as supporting faster approvals while maintaining safety standards. - The NHS spent over £5 billion on medical device procurement in the 2021-2022 financial year. - The government is aiming to raise overall healthcare spending by 3.5% annually. - England remained the market leader because of NHS procurement and stronger healthcare infrastructure. - Scotland, Wales, and Northern Ireland were described as growing markets supported by devolved healthcare investment.

Between the lines: - The report shows the UK market is being pulled by two forces at once: more patients with long-term conditions and faster adoption of digital care tools. - Software, remote monitoring, and telehealth appear to be moving from add-ons to core product categories. - Sustainability is becoming a buying factor as manufacturers introduce eco-friendly products and healthcare providers look for lower-waste options. - The competitive field looks moderately fragmented, which can create room for both global players and niche specialists. - Medtronic expanded its connected-care push with a December 2025 partnership focused on AI-enabled remote monitoring. - Johnson & Johnson launched eco-friendly surgical instruments in November 2025. - Siemens Healthineers acquired an imaging startup in October 2025. - WHO data cited in the report said noncommunicable diseases account for 74% of global deaths, while IHME said the global disease burden exceeds 2.5 billion DALYs.

What's next: - The report expects AI-driven diagnostics, telehealth, remote monitoring, and biodegradable implants to attract new investment through 2035. - Continued NHS procurement and regulatory adaptation could speed adoption of new devices across care settings. - Demand is likely to stay strongest in imaging, diagnostics, monitoring, and software-based products as care moves more toward prevention and home-based treatment. - Other key companies mentioned in the market include Philips, GE Healthcare, Baxter International, Stryker, Boston Scientific, and Abbott Laboratories. - More related research is available through Market Research Future's report library.